| Literature DB >> 29065900 |
Nicholas A Clark1, Marc Hafner2, Michal Kouril3, Elizabeth H Williams2, Jeremy L Muhlich2, Marcin Pilarczyk1, Mario Niepel2, Peter K Sorger2, Mario Medvedovic4.
Abstract
BACKGROUND: Quantifying the response of cell lines to drugs or other perturbagens is the cornerstone of pre-clinical drug development and pharmacogenomics as well as a means to study factors that contribute to sensitivity and resistance. In dividing cells, traditional metrics derived from dose-response curves such as IC 50 , AUC, and E max , are confounded by the number of cell divisions taking place during the assay, which varies widely for biological and experimental reasons. Hafner et al. (Nat Meth 13:521-627, 2016) recently proposed an alternative way to quantify drug response, normalized growth rate (GR) inhibition, that is robust to such confounders. Adoption of the GR method is expected to improve the reproducibility of dose-response assays and the reliability of pharmacogenomic associations (Hafner et al. 500-502, 2017).Entities:
Keywords: Bioconductor; Data analysis; Dose response; Emax; GR metrics; GR50; GRmax; IC50; NIH LINCS program; R package; Shiny; Web interface
Mesh:
Year: 2017 PMID: 29065900 PMCID: PMC5655815 DOI: 10.1186/s12885-017-3689-3
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Fig. 1GRcalculator Shiny applications (grtutorial, grcalculator, and grbrowser) (http://www.grcalculator.org). A schematic of the GRcalculator homepage showing links to each of the Shiny applications that comprise it
Fig. 2Dose–response model interactive Exploration Tool. Interactive graphs with parameters controlled by sliders show the behavior of the traditional dose–response curve (center) versus that of the normalized growth rate inhibition (GR) curve (right). Derived traditional dose–response model parameters IC and E are displayed along with the analogous GR model parameters GR and GR . Cell population growth at different concentrations of a drug is shown over a typical 3-day assay (left). Traditional dose–response curve values and GR curve values at these concentrations are marked by similarly colored points on the center and right plots. Buttons (bottom) set parameter values to those of a typical cytostatic, partial cytostatic, or cytotoxic drug
Fig. 3Calculating GR values and fitting dose–response curves for user-supplied data. A flowchart showing a typical GRcalculator workflow
Fig. 4Mining LINCS and published datasets. A flowchart showing a typical GRbrowser workflow
Fig. 5GRmetrics R package. Sample code and output showing generation of an interactive visualization of GR dose–response curves using the GRmetrics R package
Fig. 6grbrowser use-case with gCSI data. An example use-case of the grbrowser with the gCSI dataset, reproducing a result from Hafner et al. [3]. Steps show how to use the grbrowser to filter the dataset to breast cancer cell lines treated with lapatinib and compare the sensitivity of wild-type PTEN cell lines with that of mutant PTEN cell lines using GR and IC . In this case, use of the GR produces a known result (p-value 0.0033), that PTEN loss-of-function mutations mediate resistance to lapatinib in breast cancer cells, which IC fails to produce at a statistically significant level (p-value 0.12) because of large differences in growth rates between the wild-type and mutant cell lines. p-values were calculated using a two-sided Wilcoxon rank-sum test. IC and GR values were capped at 31 μM